CVA Family Office LLC Sells 135 Shares of HCA Healthcare, Inc. (NYSE:HCA)

CVA Family Office LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 22.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 470 shares of the company’s stock after selling 135 shares during the period. CVA Family Office LLC’s holdings in HCA Healthcare were worth $79,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in HCA. Baltimore Washington Financial Advisors Inc. acquired a new position in shares of HCA Healthcare during the fourth quarter worth $26,000. GoalVest Advisory LLC acquired a new position in shares of HCA Healthcare during the first quarter worth $26,000. Wolff Wiese Magana LLC increased its position in shares of HCA Healthcare by 1,833.3% in the 1st quarter. Wolff Wiese Magana LLC now owns 116 shares of the company’s stock valued at $29,000 after acquiring an additional 110 shares during the period. J.W. Cole Advisors Inc. acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $29,000. Finally, San Luis Wealth Advisors LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $35,000. 65.75% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Bank of America upped their target price on HCA Healthcare from $192.00 to $230.00 in a research report on Sunday, July 24th. Stephens upped their price target on shares of HCA Healthcare to $230.00 in a report on Monday, July 25th. Cowen lowered their price target on shares of HCA Healthcare to $238.00 in a report on Monday, July 25th. The Goldman Sachs Group lowered their price target on shares of HCA Healthcare from $270.00 to $233.00 and set a “buy” rating on the stock in a report on Tuesday, July 12th. Finally, Citigroup lowered their price target on shares of HCA Healthcare from $254.00 to $240.00 in a report on Tuesday, July 26th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $239.14.

HCA Healthcare Trading Down 0.6 %

Shares of HCA Healthcare stock opened at $208.39 on Tuesday. The firm has a market capitalization of $59.81 billion, a PE ratio of 10.02, a P/E/G ratio of 1.59 and a beta of 1.72. HCA Healthcare, Inc. has a twelve month low of $164.47 and a twelve month high of $279.02. The firm’s 50-day moving average price is $203.23 and its 200 day moving average price is $215.98. The company has a current ratio of 1.55, a quick ratio of 1.32 and a debt-to-equity ratio of 87.46.

HCA Healthcare (NYSE:HCAGet Rating) last issued its quarterly earnings results on Friday, July 22nd. The company reported $4.21 earnings per share for the quarter, beating analysts’ consensus estimates of $3.67 by $0.54. The firm had revenue of $14.82 billion for the quarter, compared to analyst estimates of $14.73 billion. HCA Healthcare had a net margin of 10.83% and a return on equity of 833.68%. HCA Healthcare’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period last year, the company posted $4.37 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 17.1 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 30th. Shareholders of record on Friday, September 16th will be issued a $0.56 dividend. The ex-dividend date is Thursday, September 15th. This represents a $2.24 dividend on an annualized basis and a yield of 1.07%. HCA Healthcare’s payout ratio is 10.77%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, major shareholder Patricia F. Elcan acquired 325 shares of the business’s stock in a transaction on Monday, July 25th. The stock was bought at an average price of $198.66 per share, for a total transaction of $64,564.50. Following the acquisition, the insider now owns 89,337 shares in the company, valued at $17,747,688.42. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.50% of the stock is owned by insiders.

About HCA Healthcare

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAGet Rating).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.